| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/01/2010 | WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators |
| 07/01/2010 | WO2010075263A2 Compounds and methods for enhancing erythropoiesis |
| 07/01/2010 | WO2010075090A2 Scopine modulators of muscarinic acetylcholine receptor |
| 07/01/2010 | WO2010075086A2 Pyrrolidinone inhibitors of pde-4 |
| 07/01/2010 | WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
| 07/01/2010 | WO2010074284A1 Pyrazolopyrimidine compound |
| 07/01/2010 | WO2010074244A1 Isoquinoline derivative |
| 07/01/2010 | WO2010073011A2 Compounds useful as medicaments |
| 07/01/2010 | WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 07/01/2010 | WO2010072607A1 Dihydropyridone amides as p2x7 modulators |
| 07/01/2010 | WO2010072599A1 Dihydropyridone ureas as p2x7 modulators |
| 07/01/2010 | WO2010072354A1 MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
| 07/01/2010 | WO2010072338A1 Alkaloid aminoester derivatives and medicinal composition thereof |
| 07/01/2010 | WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands |
| 07/01/2010 | WO2010047928A3 Methods and compositions for treatment of fibrosis |
| 07/01/2010 | WO2010033977A3 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 07/01/2010 | WO2010027594A3 Cinnamic acid-based oligomers and uses thereof |
| 07/01/2010 | WO2010024956A3 Antihistamine and antihistamine-like nasal application, products, and method |
| 07/01/2010 | WO2010003472A3 Lozenge composition for treating inflammatory diseases of the mouth and pharynx |
| 07/01/2010 | US20100168245 Preparation of (r,r)-fenoterol and (r,r)-or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 07/01/2010 | US20100168227 Preventative Treatment and Remission of Allergic Diseases |
| 07/01/2010 | US20100168210 T-Cell Cytokine-Inducing Surface Molecules and Methods of Use |
| 07/01/2010 | US20100168204 Therapeutic uses of inhibitors of RTP801L |
| 07/01/2010 | US20100168196 N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them |
| 07/01/2010 | US20100168192 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions |
| 07/01/2010 | US20100168170 Piperidinones Useful in the Treatment of Inflammation |
| 07/01/2010 | US20100168169 Substituted 1,3-dioxanes useful as ppar modulators |
| 07/01/2010 | US20100168167 Piperidinones Useful in the Treatment of Inflammation |
| 07/01/2010 | US20100168161 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 07/01/2010 | US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168151 Novel processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of pde iv inhibitors |
| 07/01/2010 | US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/01/2010 | US20100168137 Combination for use in the treatment of inflammatory disorders |
| 07/01/2010 | US20100168124 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 07/01/2010 | US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders |
| 07/01/2010 | US20100168094 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168077 Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof |
| 07/01/2010 | US20100168076 Diphenyl substituted alkanes |
| 07/01/2010 | US20100168054 Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation |
| 07/01/2010 | US20100168053 Oral delivery system for methylcobalamin to treat disorders |
| 07/01/2010 | US20100168023 Injectable Botulinum Toxin Formulations |
| 07/01/2010 | US20100168005 Pyridin-3-yl derivatives as immunomodulating agents |
| 07/01/2010 | US20100168002 Therapeutic peptides |
| 07/01/2010 | US20100167352 Infectious clones |
| 07/01/2010 | US20100166890 Antitussive composition and method for making the same |
| 07/01/2010 | US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders |
| 07/01/2010 | US20100166839 Non peptidic renin inhibitors nitroderivatives |
| 07/01/2010 | US20100166805 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/01/2010 | US20100166778 Toll-Like Receptor 3 Antagonists |
| 07/01/2010 | US20100166766 Engineered anti-tslp antibody |
| 07/01/2010 | US20100166749 Polypeptide variants with altered effector function |
| 07/01/2010 | US20100166736 Immunostimulatory oligonucleotide multimers |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166674 Transdermal delivery rate control using amorphous pharmaceutical compositions |
| 07/01/2010 | US20100166671 Organic compounds |
| 07/01/2010 | US20100166670 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 07/01/2010 | DE102009005059A1 Hustenmittelzusammensetzung und Verfahren zur Herstellung derselben Cough suppressant composition and method for producing the same |
| 07/01/2010 | CA2748105A1 Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the .beta.2 adrenergic receptor |
| 07/01/2010 | CA2748100A1 Alkaloid aminoester derivatives and medicinal composition thereof |
| 07/01/2010 | CA2747996A1 Compounds and methods for enhancing erythropoiesis |
| 07/01/2010 | CA2747795A1 Isoquinoline derivative |
| 07/01/2010 | CA2746561A1 Dihydropyridone amides as p2x7 modulators |
| 07/01/2010 | CA2745952A1 Dihydropyridone amides as p2x7 modulators |
| 07/01/2010 | CA2745866A1 Dihydropyridone ureas as p2x7 modulators |
| 06/30/2010 | EP2202240A1 Compound |
| 06/30/2010 | EP2202231A1 2,3-dihydroiminoisoindole derivative |
| 06/30/2010 | EP2201964A2 Formoterol superfine formulation |
| 06/30/2010 | EP2201936A1 Method of treating acute rhinosinusitis |
| 06/30/2010 | EP2200615A1 A3 adenosine receptor antagonists |
| 06/30/2010 | EP2200608A1 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of life in lung diseases |
| 06/30/2010 | EP2200603A2 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 06/30/2010 | EP1891008B1 Oxindoles as kinase inhibitors |
| 06/30/2010 | EP1689433B1 Compositions and methods for activating innate and allergic immunity |
| 06/30/2010 | EP1545548B1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 06/30/2010 | EP1330436B1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | CN1895408B Radix saposhnikoviae Tong Sheng capsules, preparation and quality control method thereof |
| 06/30/2010 | CN1836568B Wild rose health food and preparation method thereof |
| 06/30/2010 | CN1796402B Technique for preparing general alkaloid of Hubei fritillary bulb |
| 06/30/2010 | CN101765593A 2-iminoisothiazole derivatives as cannabinoid receptor ligands |
| 06/30/2010 | CN101765442A organic compounds |
| 06/30/2010 | CN101765431A A method of administration of a pulmonary surfactant |
| 06/30/2010 | CN101762673A Method for detection of illegally added chemical in traditional Chinese medicine preparation |
| 06/30/2010 | CN101760377A Wine for reducing internal heat and manufacturing method thereof |
| 06/30/2010 | CN101760340A Candle for treating cold |
| 06/30/2010 | CN101760334A Candle with effect of clearing away lung-heat |
| 06/30/2010 | CN101760330A Candle with healthcare function on respiratory tract and digestive system |
| 06/30/2010 | CN101759806A Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof |
| 06/30/2010 | CN101759760A Preparation of fluorine-containing steroid hormone |
| 06/30/2010 | CN101759672A Salvianolic acid B in radix salviae miltiorrhizae |
| 06/30/2010 | CN101759642A Method for preparing high purity dimemorfan and phosphate |
| 06/30/2010 | CN101759628A Ethynylindole compounds |
| 06/30/2010 | CN101757638A Nasal medicine composition enclosing budesonide by cyclodextrin |
| 06/30/2010 | CN101757637A Nasal pharmaceutical composition adopting cyclodextrin to include triamcinolone acetonide or 21-acetic ester thereof |
| 06/30/2010 | CN101757636A Nasal pharmaceutical composition adopting cyclodextrin to include ciclesonide |
| 06/30/2010 | CN101757635A Nasal pharmaceutical composition adopting cyclodextrin to include methylprednisolone aceponate |
| 06/30/2010 | CN101757634A Nasal medicine composition enclosing fluticasone propionate by cyclodextrin |
| 06/30/2010 | CN101757629A Medicine composition for treating acute and chronic aryngitis and preparation method thereof |
| 06/30/2010 | CN101757625A Nasal pharmaceutical composition of cyclodextrin inclusion cortin and H1 receptor antagonist |
| 06/30/2010 | CN101757612A Gama-interferon high-efficient injection liquid for chickens and preparation method thereof |